179 related articles for article (PubMed ID: 25238446)
1. Rare presentation of secondary cutaneous involvement by splenic marginal zone lymphoma: report of a case and review of the literature.
Cohen JM; Nazarian RM; Ferry JA; Takvorian RW; Carter JB
Am J Dermatopathol; 2015 Jan; 37(1):e1-4. PubMed ID: 25238446
[TBL] [Abstract][Full Text] [Related]
2. A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease.
Mittal N; Zhu B; Gaitonde S; Lu Y; Schmidt ML
Pediatr Blood Cancer; 2015 May; 62(5):905-8. PubMed ID: 25663537
[TBL] [Abstract][Full Text] [Related]
3. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
Carter SJ; Bernstein SH; Friedberg JW; Barr PM
Leuk Res; 2011 Nov; 35(11):e223-4. PubMed ID: 21824654
[No Abstract] [Full Text] [Related]
5. First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas.
Castelli R; Bergamaschini L; Deliliers GL
Med Oncol; 2017 Dec; 35(2):15. PubMed ID: 29288421
[TBL] [Abstract][Full Text] [Related]
6. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
Olszewski AJ; Ali S
Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
[TBL] [Abstract][Full Text] [Related]
7. Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
Kiesewetter B; Mayerhoefer ME; Lukas J; Zielinski CC; Müllauer L; Raderer M
Ann Hematol; 2014 Feb; 93(2):249-53. PubMed ID: 23925930
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
9. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
10. Intrapericardial and intrapleural administration of rituximab to a patient with marginal zone lymphoma.
Boguradzki P; Drozd-Sokolowska JE; Wieczorek J; Kowalik R; Starczewska M; Krol M; Kobylecka M; Opolski G; Wiktor-Jedrzejczak W
Acta Haematol; 2013; 130(3):169-71. PubMed ID: 23735747
[TBL] [Abstract][Full Text] [Related]
11. Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine.
Scapinello G; Pizzi M; Vio S; Nabergoj M; Visentin A; Martines A; Bonaldi L; Trentin L; Semenzato G; Piazza F
Ann Hematol; 2018 Oct; 97(10):2001-2003. PubMed ID: 29728736
[No Abstract] [Full Text] [Related]
12. Primary cutaneous marginal zone lymphoma as a complication of radiation therapy: Case report and review.
Breton AL; Poulalhon N; Balme B; Thomas L; Dalle S
Dermatol Online J; 2010 Dec; 16(12):6. PubMed ID: 21199632
[TBL] [Abstract][Full Text] [Related]
13. Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement.
Beltrán BE; Castillo JJ; Quiñones P; Morales D; Paredes A; Nieto G; Miranda RN; Torres-Cabala CA
Am J Dermatopathol; 2014 Nov; 36(11):e189-93. PubMed ID: 25238445
[TBL] [Abstract][Full Text] [Related]
14. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature.
Angelopoulou MK; Vassilakopoulos TP; Konstantinou E; Boutsikas G; Asimakopoulos JV; Triantafyllou EF; Petevi K; Kanellopoulos A; Moschogiannis M; Pangalis GA; Siakantaris MP; Konstantopoulos K
Hematol Oncol; 2019 Apr; 37(2):219-222. PubMed ID: 30592785
[No Abstract] [Full Text] [Related]
16. Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma.
Schaefer IM; Marx A; Sauer C; Hohloch K; Ghadimi BM; Trümper L; Ströbel P
Histopathology; 2013 Mar; 62(4):664-7. PubMed ID: 23379885
[No Abstract] [Full Text] [Related]
17. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous marginal zone lymphoma in children: a report of 3 cases and review of the literature.
Kempf W; Kazakov DV; Buechner SA; Graf M; Zettl A; Zimmermann DR; Tinguely M
Am J Dermatopathol; 2014 Aug; 36(8):661-6. PubMed ID: 24698939
[TBL] [Abstract][Full Text] [Related]
19. Recurrent localized primary cutaneous marginal-zone B cell lymphoma.
Marmon S; Chu J; Patel R; Meehan S; Pomeranz MK
Dermatol Online J; 2011 Oct; 17(10):27. PubMed ID: 22031653
[TBL] [Abstract][Full Text] [Related]
20. Remission of Cutaneous Involvement in Splenic Marginal Zone Lymphoma after Splenectomy.
Mai S; Natsuga K; Shiratori S; Takahashi Y; Shimizu H
Acta Derm Venereol; 2018 Aug; 98(8):801-802. PubMed ID: 29856467
[No Abstract] [Full Text] [Related]
[Next] [New Search]